Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 90601

2 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
July 13, 2022
Product types
Drug
Classifications
Class II
Statuses
Terminated
Recalling firm wording
Dr. Reddy's Laboratories, Inc.

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

2 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 2

Lansoprazole Delayed-Release Orally Disintegrating Tablets, 15 mg, 100-count blisters per carton, 10 Packs of 10 Tablets Each, Rx Only, Distributed by: Dr. Reddy's Laboratories, Inc., Princeton, NJ 08540, Made in India, blister barcode 4359856079, NDC 43598-560-78

D-1287-2022
Recall number
D-1287-2022
Initiated
July 13, 2022
Classification
Class II
Status
Terminated
Quantity
2,892 cartons

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0
FAILED DISSOLUTION SPECIFICATIONS

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

FAILED DISSOLUTION SPECIFICATIONS

Code information

Lot T2100514, Exp 01/2023

Distribution pattern

Nationwide in the USA

drug · product 2 of 2

Lansoprazole Delayed-Release Orally Disintegrating Tablets, 35 mg, 100-count blisters per carton, 10 Packs of 10 Tablets Each, Rx Only, Distributed by: Dr. Reddy's Laboratories, Inc., Princeton, NJ 08540, Made in India, blister barcode 4359856179, NDC 43598-561-78

D-1288-2022
Recall number
D-1288-2022
Initiated
July 13, 2022
Classification
Class II
Status
Terminated
Quantity
2,639 cartons

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0
FAILED DISSOLUTION SPECIFICATIONS

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

FAILED DISSOLUTION SPECIFICATIONS

Code information

Lot T2100515, Exp 01/2023

Distribution pattern

Nationwide in the USA